E-mail us:
service@prospectnews.com
Or call: 212 374 2800
Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
Add to balance / Manage account
Not logged in
Prospect News home
>
Main news index
>
All issuers starting with T
>
Issuers starting with T, PP only
>
All stories on Transition Therapeutics Inc.
>
Stories on Transition Therapeutics Inc., PP only
Search again
Enter part or all of the issuer name:
Market:
All markets
No structured products
Bank loans
Canadian bonds
CLOs
Convertibles
Distressed debt
Emerging markets
High yield
Investment grade
Liability management
Municipals
PIPEs
Preferreds
Private placements
All leveraged markets
Structured products
Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each.
All others are $1.00 each. Headlines in
gray
are not currently covered by your subscription.
Transition Therapeutics Inc.
2/18/2015
PP
Transition greenshoe exercised for $23 million public shares offering
2/12/2015
PP
Transition Therapeutics prices $20 million public offering of shares
2/11/2015
PP
Transition Therapeutics launches public offering of common stock
1/6/2015
PP
Transition Therapeutics plans $25 million at-the-market sale of stock
6/6/2014
PP
Transition Therapeutics to sell $17 million of units through placement
8/2/2013
PP
Transition Therapeutics plans $11 million private placement of units
11/21/2011
PP
Transition Therapeutics prices $5 million private placement of shares
7/6/2007
PP
Market Commentary:
Grill Concepts sets $14.09 million unit offering; MIV Therapeutics secures $12.55 million
7/5/2007
PP
Market Commentary:
FX Energy to close $12.95 million offering; Deep Well wraps $5 million stock sale
7/5/2007
PP
New Issue: Transition Therapeutics prices C$25 million placement of shares
11/7/2006
PP
Market Commentary:
Cytogen to seal $20 million private placement; biotechs lead PIPE activity
11/7/2006
BTPP
New Issue: Transition Therapeutics to close C$25 million placement of stock
©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.